- Oops!Something went wrong.Please try again later.
Nineteen years ago I made the smartest investment of my life, followed a few months later by my dumbest decision.
Shares of Merck & Co. (NYSE: MRK) were trading 5.5% lower as of 12:46 p.m. ET on Monday. The decline came after Citi analyst Andrew Baum downgraded the stock from buy to neutral, and lowered his 12-month price target on it from $105 to $85. In this case, Baum's downgrade decision was driven by a pair of significant disappointments that Merck reported in recent weeks.
-- in which its stock shed 3.6%, shares of semiconductors star Nvidia (NASDAQ: NVDA) are bouncing back Monday morning, up 2.8% as of 11 a.m. ET. The reason: I suspect investors are shrugging off last week's bad coronavirus news and focusing on some good Nvidia news that got overlooked. Specifically, I mean the news that on Friday analysts at investment bank Bank of America doubled down on their buy rating on Nvidia stock.
After sliding along with the rest of the stock market on Friday, shares of lithium mining stock Lithium Americas (NYSE: LAC) are rebounding in a big way on Monday -- up 13.6% as of 12:15 p.m. ET. You can thank the friendly analysts at National Bank Financial for that. No sooner had Lithium Americas finished its Friday slide than an analyst at the Canadian investment bank stepped in and reiterated an outperform recommendation on the stock.
Wall Street has known its share of legends, but few of them have made as big a splash as “the Man Who Broke the Bank of England.” That nickname belongs to George Soros who earned the tag after famously betting against the British Pound in 1992; following the Black Wednesday crash, the hedge fund manager pocketed a $1 billion in a single day. This is the stuff that Wall Street legends are made of. By then Soros was already incredibly successful and in the midst of steering his Quantum Fund to dec
Shares of Krystal were up 120% in Monday trading on the company's report of initial data from the pivotal trial of its Vyjuvek treatment.
The technology powering virtual reality (VR) experiences has significantly improved in recent years. This technology is powering real-world applications like virtual walkthroughs of buildings and products still on the drawing board, or collaborations with colleagues in a virtual meeting room. Facebook has made a big splash into this new "metaverse" by changing its name to Meta Platforms (NASDAQ: FB), but that's not the only way to play this trend as an investor.
Words have power -- as investors discovered to their dismay last week. News of the new omicron variant of COVID-19 shocked the stock market, sending shares of cruise line stocks Royal Caribbean (NYSE: RCL), Carnival (NYSE: CCL) (NYSE: CUK), and Norwegian Cruise Line Holdings (NYSE: NCLH) tumbling 10% and more in Friday trading.
Electric vehicle stocks are back to trading more on the progress in their business, and less on splashy IPO hype.
Microsoft (NASDAQ: MSFT) recently became a hot topic after CEO Satya Nadella sold more than half of his shares for about $285 million on Nov. 22 and 23. When Nadella took over as Microsoft's third CEO in 2014, the tech giant was in serious trouble. Microsoft's cloud business became its core growth engine, and the company's revenue surged from $86.8 billion in fiscal 2014 to $168.1 billion in fiscal 2021, which ended this June, as its earnings per share more than tripled.
Shares of Tesla (NASDAQ: TSLA) rose sharply on Monday. The growth stock's sharp gain was likely due to reports over the weekend that Tesla is set to begin production at its new factory in Germany by next month. On an overall bullish Monday for stocks, the S&P 500 was up nearly 1% as of this writing, and the Nasdaq Composite was up about 1.3%.
Bionano Genomics, BioCryst Pharmaceuticals, and NRx Pharmaceuticals all have the potential to make their early shareholders rich.
These stocks could still provide amazing returns for the next decade, despite their already-impressive growth.
Vertex Pharmaceuticals (NASDAQ: VRTX) has given more than one investor a headache over the past year. Investors worry that Vertex is struggling to expand beyond its core portfolio of cystic fibrosis (CF) treatments. Considering the time Vertex shares have spent in the doldrums, you may be getting a little impatient.
In this daily bar chart of CRWD, below, we can see that prices have declined this month to break below the cresting 200-day moving average line. The On-Balance-Volume (OBV) line has been weak the past three months as sellers of CRWD have been more aggressive. In this weekly Japanese candlestick chart of CRWD, below, we see a mixed picture.
Paysafe Limited ( NYSE:PSFE ) is possibly approaching a major achievement in its business, so we would like to shine...
Although it's been a dud of a performer in 2021, telehealth platform Teladoc Health (NYSE: TDOC) is a holding I fully expect to deliver 10X (or greater) returns by the time I'm ready to enjoy retirement. While some folks would opine that Teladoc was lucky to be in the right place at the right time when the pandemic struck, I'd contend that they're not looking at the bigger picture. For instance, in the six years leading up to the pandemic, Teladoc's average annual sales grew by 74%.
Capital gains taxes on real estate and property can be reduced when you sell your home, up to certain tax limits, if you meet the requirements.
(Reuters) -Three U.S. House Democrats on Monday asked the head of the Federal Aviation Administration (FAA) to provide more details of the agency's oversight of Boeing's 737 MAX and questioned whether the planemaker had been held fully accountable. The lawmakers, including House Transportation and Infrastructure chairman Peter DeFazio, asked FAA Administrator Steve Dickson in a letter Monday what the agency had done, if anything to hold Boeing employees responsible for various transgressions. The letter said these included Boeing's apparent violation of its approved 737 MAX type design, as well as evidence of an internal plan to downplay the significance of a key safety system called MCAS tied to both fatal crashes.
A new analysis compared the Radnor firm's potential treatment to other therapies now being used to treat Covid-19.
Galaxy Digital Holdings Ltd. (TSX: GLXY) ("GDH Ltd." or the "Company") is pleased to announce that Galaxy Digital Holdings LP (the "Issuer" and together with GDH Ltd., "Galaxy Digital") has agreed to issue and sell $500 million aggregate principal amount of 3.00% Exchangeable Senior Notes due 2026 (the "Notes") to certain purchasers, including affiliates of Arca, NZ Funds, Senator Investment Group and XN (the "Noteholders"), in a private placement under the Securities Act of 1933, as amended (th